| Muhammad Asad, | |
|
2300 N Edward St, Decatur, IL 62526-4163 | |
| (217) 876-3660 | |
| (217) 876-3665 |
| Full Name | Muhammad Asad |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 2300 N Edward St, Decatur, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245882448 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 036159900 (Illinois) | Primary |
| Entity Name | Pana Community Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942326970 PECOS PAC ID: 3274437348 Enrollment ID: O20031121000350 |
News Archive
The not-for-profit Sutter Health network announced today that it reached agreement on a new two-year contract with Blue Shield of California, preserving patient access to the doctors and care centers that Blue Shield sold to patients during fall open enrollment.
Our immune system plays an essential role in protecting us from diseases, but how does it do this exactly?
An analysis of Geisinger's electronic health records has revealed chronic kidney disease to be the leading risk factor for hospitalization from COVID-19.
Lundbeck LLC today announced that the U.S. Food and Drug Administration has accepted for review a New Drug Application (NDA) for its investigational therapy intravenous carbamazepine, an intravenous formulation of the anti-epileptic drug (AED) carbamazepine. An action letter is anticipated before the end of 2014. Carbella is the proposed U.S. trade name for intravenous carbamazepine.
An antibody treatment successfully protected nonhuman primates against the deadly Marburg and Ravn viruses even when given five days after becoming infected, according to the latest findings of a collaborative team from The University of Texas Medical Branch at Galveston, Mapp Biopharmaceutical Inc., and Vanderbilt University. The findings are now available in Science Translational Medicine.
› Verified 6 days ago
| Entity Name | Decatur Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164477725 PECOS PAC ID: 6204731144 Enrollment ID: O20031203000685 |
News Archive
The not-for-profit Sutter Health network announced today that it reached agreement on a new two-year contract with Blue Shield of California, preserving patient access to the doctors and care centers that Blue Shield sold to patients during fall open enrollment.
Our immune system plays an essential role in protecting us from diseases, but how does it do this exactly?
An analysis of Geisinger's electronic health records has revealed chronic kidney disease to be the leading risk factor for hospitalization from COVID-19.
Lundbeck LLC today announced that the U.S. Food and Drug Administration has accepted for review a New Drug Application (NDA) for its investigational therapy intravenous carbamazepine, an intravenous formulation of the anti-epileptic drug (AED) carbamazepine. An action letter is anticipated before the end of 2014. Carbella is the proposed U.S. trade name for intravenous carbamazepine.
An antibody treatment successfully protected nonhuman primates against the deadly Marburg and Ravn viruses even when given five days after becoming infected, according to the latest findings of a collaborative team from The University of Texas Medical Branch at Galveston, Mapp Biopharmaceutical Inc., and Vanderbilt University. The findings are now available in Science Translational Medicine.
› Verified 6 days ago
| Entity Name | Taylorville Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518170729 PECOS PAC ID: 8022914704 Enrollment ID: O20031211001049 |
News Archive
The not-for-profit Sutter Health network announced today that it reached agreement on a new two-year contract with Blue Shield of California, preserving patient access to the doctors and care centers that Blue Shield sold to patients during fall open enrollment.
Our immune system plays an essential role in protecting us from diseases, but how does it do this exactly?
An analysis of Geisinger's electronic health records has revealed chronic kidney disease to be the leading risk factor for hospitalization from COVID-19.
Lundbeck LLC today announced that the U.S. Food and Drug Administration has accepted for review a New Drug Application (NDA) for its investigational therapy intravenous carbamazepine, an intravenous formulation of the anti-epileptic drug (AED) carbamazepine. An action letter is anticipated before the end of 2014. Carbella is the proposed U.S. trade name for intravenous carbamazepine.
An antibody treatment successfully protected nonhuman primates against the deadly Marburg and Ravn viruses even when given five days after becoming infected, according to the latest findings of a collaborative team from The University of Texas Medical Branch at Galveston, Mapp Biopharmaceutical Inc., and Vanderbilt University. The findings are now available in Science Translational Medicine.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Muhammad Asad, 2300 N Edward St Ste 3200, Decatur, IL 62526-4163 Ph: (217) 876-3651 | Muhammad Asad, 2300 N Edward St, Decatur, IL 62526-4163 Ph: (217) 876-3660 |
News Archive
The not-for-profit Sutter Health network announced today that it reached agreement on a new two-year contract with Blue Shield of California, preserving patient access to the doctors and care centers that Blue Shield sold to patients during fall open enrollment.
Our immune system plays an essential role in protecting us from diseases, but how does it do this exactly?
An analysis of Geisinger's electronic health records has revealed chronic kidney disease to be the leading risk factor for hospitalization from COVID-19.
Lundbeck LLC today announced that the U.S. Food and Drug Administration has accepted for review a New Drug Application (NDA) for its investigational therapy intravenous carbamazepine, an intravenous formulation of the anti-epileptic drug (AED) carbamazepine. An action letter is anticipated before the end of 2014. Carbella is the proposed U.S. trade name for intravenous carbamazepine.
An antibody treatment successfully protected nonhuman primates against the deadly Marburg and Ravn viruses even when given five days after becoming infected, according to the latest findings of a collaborative team from The University of Texas Medical Branch at Galveston, Mapp Biopharmaceutical Inc., and Vanderbilt University. The findings are now available in Science Translational Medicine.
› Verified 6 days ago
Dr. Jeffrey P Wilson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2300 N Edward St, Decatur, IL 62526 Phone: 217-876-8121 | |
Dr. Jeanne Marie Kairouz, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1770 E Lake Shore Dr Ste 105, Decatur, IL 62521 Phone: 217-422-6100 | |
Dr. Stephen R Goetter, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 304 W Hay St, Ste 312, Decatur, IL 62526 Phone: 217-876-5600 Fax: 217-876-5664 | |
Dr. Prameeta Jha, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2300 N Edward St Ste 3200, Decatur, IL 62526 Phone: 217-876-3660 Fax: 217-876-3665 | |
David W Baumberger, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 304 W Hay St, Ste 312, Decatur, IL 62526 Phone: 217-876-5600 Fax: 217-876-5664 | |
Dr. Ahmad H Ahmad, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1770 E Lake Shore Dr, Suite 201, Decatur, IL 62521 Phone: 217-428-7921 Fax: 217-428-7931 | |
Nadal M Aker, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2300 N Edward St, Suite 2400, Decatur, IL 62526 Phone: 217-876-2400 Fax: 217-876-2405 |